Related Experiment Video

Updated: Jun 20, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Synthetic peptide-based cancer vaccines: lessons learned and hurdles to overcome

Caroline J Voskens1, Scott E Strome, Duane A Sewell

  • 1Department of Pathology, University of Maryland, 16 South Eutaw Street, Suite 500, Baltimore, MD 21201-168, USA.

Current Molecular Medicine
|August 20, 2009
PubMed

Insights

Peptide cancer vaccines often fail to shrink tumors despite stimulating T cell immunity. Improving these vaccines requires addressing patient variability and enhancing CD4+ T cell help for better immune responses.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Peptide-based cancer vaccines frequently fail to induce tumor regression, despite eliciting T cell responses.
  • This review examines the challenges hindering the clinical success of synthetic peptide cancer vaccines.

Purpose of the Study:

  • To understand the reasons behind the limited efficacy of peptide cancer vaccines.
  • To identify key hurdles in the application of peptide-based vaccines.
  • To propose strategies for improving peptide vaccine effectiveness.

Main Methods:

  • Review of existing studies on peptide cancer vaccines.
  • Analysis of factors contributing to vaccine failure, including patient variability and epitope selection.
  • Discussion of the role of CD4+ T cell help in vaccine strategies.

Main Results:

  • Patient variability and suboptimal epitope selection are significant barriers.
  • CD4+ T cell help is crucial for effective peptide-based vaccine strategies.
  • Generating both HLA class I and class II immune responses may enhance vaccine efficacy.

Conclusions:

  • Overcoming challenges like patient variability and enhancing T cell help are critical for successful peptide cancer vaccines.
  • Strategies focusing on both CD4+ and CD8+ T cell responses are needed.
  • Future peptide vaccine designs should consider comprehensive immune activation for clinical benefit.

More Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...